Skip to content

Welcome

Celebrating Over 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

AAOA Member Benefits

  • Up to 60% discount for CME programs and free Annual Meeting. All AAOA’s CME programs meet ABOTOHNS Continuing Certification.
  • AAOA US ENT Affinity program, where AAOA members can gain savings on antigen, allergy supplies, and any of the other 5 service lines US ENT offers. For more email info@usentpartners.com.
  • Tools and resources to comply with US General Chapter 797 and practice management tools.
  • Advocacy support.
  • And much more! Learn More

ADVOCACY UPDATES

Upcoming Dates

04/01/24: Fellow Exam Application Deadline
Learn more

06/01/24: Research Grant Cycle
Learn more

06/25/24: Membership Application Deadline to be eligible for AAOA Member rate for the 2024 Basic Course

08/02/24: Scientific Abstract Submission Deadline
Learn more

12/01/24: Research Grant Cycle
Learn more

EDUCATION

AAOA Advanced Course

The recorded course content is available until April 30, 2024. This year’s Advanced Course featured Laryngology and Skull Base Surgery with Nausheen Jamal, MD and Garret Choby, MD as featured faculty.

RESIDENTS

For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More

IFAR

Available Now

aaoaf-ifar

IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2024 AAOA Advanced Course in Allergy & Immunology - Hybrid
On-Demand Content Access Deadline:
April 30, 2024
Learn More and Register

2024 AAOA Basic Course in Allergy & Immunology - Hybrid
July 25-27, 2024
The Diplomat, Hollywood, Florida
Learn More and Register

2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas
Learn More 

USP 797 Online Module
Learn More and Register

AAOA Educational Stacks
Next Availability - April 1, 2024

News and Updates

Choose the IndependENT 2018 AAOA Annual Meeting!

Building off the success of our radically re-designed Chicago Annual Meeting, we look forward to…

Read more

Why 2017 AAOA Advanced Course in Allergy & Immunology

By Cecelia Damask, DO, Director of Educational Programs Due to popular demand, the AAOA is excited…

Read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

American Elm Shortage

American Elm is dying from Dutch Elm Disease. This may explain the concentrate shortage many practices and antigen suppliers are experiencing.

To help, there are many other elm species that are more or less resistant to this fungal disease and still cause allergic symptoms.  There is little cross-reactivity outside the elm family, so the best bet to overcome the shortage and help your patients is to substitute another elm species for allergen testing and immunotherapy.

Several Elm species are commercially available, including Slippery Elm and Chinese Elm.  Other options to consider include Mulberry, Hemp, and Hops — all closely related.  None of these substitutes are going to be exact matches, either for antigen profile or for potency.  Additionally, you can discuss further with the pharmacist at your Antigen source company to identify the most readily available cross-reactive option.  

Whichever you choose to use to replace American Elm will require mandatory vial testing for each patient who is switched to the new antigen. Best option to consider when replacing American Elm for Chinese Elm on your mixing board is to cut back one 5-fold dilution (5-fold) and then do a vial check.  Retesting is not necessary.  

For those with patients on monthly maintenance injections, you may need to re-escalate. With the recommendation of  a 1:5 dilution with the addition of the new Elm product, that implies the need for re-escalating back to the maintenance dose. If the patient is on monthly injections, and you use the standard AAOA escalation, it would take nearly 2 years to get back up to full maintenance dose or the patient will need to go back to weekly injections for five months until get back to full maintenance. You may want to consider a more rapid weekly re-escalation for a patient already on monthly maintenance, such as 0.1, 0.2, 0.3, 0.4, and 0.5 , which would cut down on the time to get back to full maintenance. This should be reasonably safe due to the cross-reactivity. 

Back To Top